Glenn Reicin

Glenn Reicin

Geen lopende functies
61 jaar
Finance
Health Technology
Consumer Services

Profiel

Glenn M.
Reicin
served as Managing Director at Morgan Stanley & Co. LLC from 1993 to 2008.
Director roles were held at Novasys Medical, Inc. (2009-2013), SpinalMotion, Inc. (2009-2014), and SI-BONE, Inc. (2010-2012).
Managing Director at Skyline Management LLC from 2009 to 2012.
Chief Financial Officer & Treasurer at Sigilon Therapeutics, Inc. from 2019 to 2021.
President of Greyrock Biomedical Advisors Ltd. from 2013 to 2019.
Titles also include Independent Director at Amplitude Healthcare Acquisition Corp., Analyst at Fidelity Management & Research Co. LLC, Senior Vice President at Oppenheimer & Co., Inc., Management Consultant at Bain & Co., Inc., Chief Financial & Operating Officer at Alladapt Immunotherapeutics, Inc., and Chief Financial Officer at Harmony Biosciences Holdings, Inc. in 2026.
Education includes undergraduate studies at Brandeis University and an MBA from Harvard Business School.

Eerdere bekende functies van Glenn Reicin

BedrijvenFunctieEinde
HARMONY BIOSCIENCES HOLDINGS, INC. Financieel Directeur/CFO 16-07-2026
SIGILON THERAPEUTICS, INC. Financieel Directeur/CFO 14-06-2021
President 01-05-2019
Directeur/Bestuurslid 01-01-2014
Directeur/Bestuurslid 01-01-2013
Ervaring van Glenn Reicin in detail bekijken

Opleiding van Glenn Reicin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

97

Eerstegraads connecties

15

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit15

Finance

Finance

Health Services

Health Technology

Health Technology

Finance

Commercial Services

Finance

Consumer Services

Consumer Services

Health Technology

Health Technology

Finance

Finance

Health Technology

  1. Beurs
  2. Insiders
  3. Glenn Reicin